ACADIA Pharmaceuticals Inc.
ACAD | NASDAQ
$26.80
+$0.41 (+1.53%)
Sep 22, 2026, 11:31 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.14B | 1.1B | 1.07B | 1.05B | 1.02B | 996.28M | 957.8M | 929.24M | 890.53M | 813.81M | 726.44M | 631.89M | 550.9M | 520.23M | 517.24M | 511.5M | 512.4M | 493.06M | 484.15M | 474.39M | 463.36M | 458.24M |
Cost of Revenue | 100.98M | 93.4M | 89M | 84.58M | 81.79M | 79.28M | 81.84M | 77.93M | 73.69M | 62.92M | 41.64M | 26.16M | 13.68M | 8.88M | 10.17M | 10.31M | 14.86M | 17.4M | 19.14M | 21.88M | 20M | 20.27M |
Gross Profit | 1.04B | 1B | 982.51M | 962.54M | 937.1M | 917M | 875.96M | 851.31M | 816.84M | 750.88M | 684.8M | 605.73M | 537.23M | 511.35M | 507.07M | 501.19M | 497.54M | 475.66M | 465M | 452.51M | 443.36M | 437.97M |
Operating Income | 86.37M | 80.91M | 104.81M | 240.92M | 236.81M | 234.87M | 230.79M | 112.24M | 22.82M | -4.59M | -73.38M | -154.39M | -127.48M | -164.16M | -223.6M | -222.19M | -206.63M | -216.68M | -170.44M | -192.94M | -263.54M | -263.84M |
Interest Income | 32.62M | 31.88M | 31.72M | 30.4M | 28.74M | 27.85M | 25.46M | 23.21M | 20.75M | 18.94M | 17.23M | 16.11M | 14.28M | 10.31M | 6.61M | 3.11M | 943K | 496K | 591K | 1.02M | 2.13M | 3.82M |
Pretax Income | 121.37M | 115.11M | 138.9M | 273.67M | 267.88M | 264.85M | 258.08M | 136.69M | 45.74M | 14.91M | -51.04M | -131.63M | -105.9M | -145.81M | -213.44M | -215.46M | -203.83M | -213.66M | -167.52M | -190.96M | -261.03M | -259.38M |
Net Income | 380.48M | 375.65M | 391M | 261.17M | 222.16M | 228.88M | 226.45M | 128.51M | 30.57M | -1.71M | -61.29M | -148.81M | -110.82M | -145.94M | -215.98M | -217.34M | -204.62M | -214.48M | -167.87M | -191.54M | -261.74M | -260.01M |
Selling & General & Admin | 620.29M | 593.54M | 548.89M | 523.36M | 523.25M | 506.81M | 488.43M | 469.81M | 434.41M | 413.31M | 406.56M | 399.5M | 379.71M | 373.65M | 369.09M | 370.6M | 374.16M | 381.05M | 396.03M | 410.87M | 410.79M | 398.35M |
Research & Development | 331.01M | 327.41M | 328.8M | 344.78M | 323.55M | 321.84M | 303.25M | 269.26M | 359.62M | 342.15M | 351.62M | 360.62M | 284.99M | 301.86M | 361.58M | 352.78M | 330.01M | 311.3M | 239.42M | 234.59M | 296.11M | 303.47M |
Other Expenses | n/a | n/a | n/a | -146.52M | -146.52M | -146.52M | -146.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 951.3M | 920.95M | 877.7M | 721.62M | 700.29M | 682.13M | 645.16M | 739.07M | 794.03M | 755.47M | 758.18M | 760.11M | 664.7M | 675.51M | 730.67M | 723.38M | 704.17M | 692.34M | 635.44M | 645.46M | 706.9M | 701.82M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.05B | 1.01B | 966.69M | 806.2M | 782.08M | 761.41M | 727M | 817M | 867.72M | 818.39M | 799.82M | 786.27M | 678.38M | 684.39M | 740.83M | 733.69M | 719.03M | 709.74M | 654.58M | 667.34M | 726.9M | 722.08M |
Income Tax Expense | -259.12M | -260.54M | -252.1M | 12.5M | 45.72M | 35.97M | 31.62M | 8.19M | 15.18M | 16.62M | 10.25M | 17.18M | 4.91M | 128K | 2.53M | 1.89M | 785K | 815K | 351K | 579K | 712K | 632K |
Shares Outstanding (Basic) | 171.6M | 170.52M | 169.34M | 168.84M | 167.83M | 166.81M | 166.36M | 165.97M | 165.55M | 164.8M | 164.81M | 164.23M | 163.46M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
Shares Outstanding (Diluted) | 172.85M | 172.71M | 171.36M | 170.65M | 168.68M | 167.67M | 166.36M | 166.18M | 166.17M | 166.62M | 166.51M | 164.23M | 165.05M | 162.26M | 161.99M | 161.85M | 161.65M | 161.23M | 160.87M | 160.66M | 160.42M | 160.01M |
EPS (Basic) | 2.25 | 2.23 | 2.32 | 1.56 | 1.33 | 1.37 | 1.36 | 0.78 | 0.18 | -0.01 | -0.38 | -0.92 | -0.69 | -0.91 | -1.34 | -1.35 | -1.27 | -1.33 | -1.05 | -1.20 | -1.65 | -1.65 |
EPS (Diluted) | 2.22 | 2.20 | 2.29 | 1.55 | 1.33 | 1.37 | 1.36 | 0.78 | 0.18 | -0.01 | -0.38 | -0.92 | -0.69 | -0.91 | -1.34 | -1.35 | -1.27 | -1.33 | -1.05 | -1.20 | -1.65 | -1.65 |
EBITDA | 116.12M | 126.91M | 150.66M | 133.62M | 127.45M | 124.06M | 119.86M | 149M | 57.2M | 25.56M | -45.48M | -127.23M | -102.71M | -143.88M | -211.42M | -213.39M | -201.28M | -210.7M | -164.52M | -188.47M | -259.86M | -260.68M |
EBIT | 104.09M | 115.11M | 138.9M | 119.57M | 113.78M | 110.76M | 103.98M | 136.69M | 45.74M | 14.91M | -51.04M | -131.63M | -105.9M | -145.81M | -213.44M | -215.46M | -203.83M | -213.66M | -167.86M | -192.12M | -263.23M | -263.84M |
Depreciation & Amortization | 12.02M | 11.8M | 11.76M | 14.05M | 13.67M | 13.31M | 15.88M | 12.31M | 11.46M | 10.65M | 5.55M | 4.4M | 3.19M | 1.94M | 2.03M | 2.07M | 2.55M | 2.97M | 3.34M | 3.65M | 3.37M | 3.16M |
Add to Watchlist
Select watchlists to add or remove ACAD